Abstract
Spinal cord injury (SCI) research is at a crossroads for progressing into legitimate science for discovering a cure. To do this, the interventions designed by basic scientists must be applied by translational processes that are planned and performed with systematic standards. Any proposed intervention should be examined under the scrutiny of a randomized, double-blind, placebo-controlled, clinical trial. To support this requirement, the National Institutes of Health has specifically defined the components of a properly run clinical trial. Furthermore, all investigational results should be published according to the Consolidated Standard of Reporting Trials (CONSORT) group, which specifies reporting guidelines for researchers to use. Finally, when it comes to designing and reporting randomized clinical trials for SCI research, unique characteristics of this patient population must be considered to adhere to valid study investigation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
